The patent summary says, The invention provides the isolated human Ebola (hEbola) viruses denoted as Bundibugyo (EboBun) deposited with the Centers for Disease Control and Prevention (CDC; Atlanta, Georgia, United States of America) on November 26, 2007 and accorded an accession number 200706291. It goes on to state, The present invention is based upon the isolation and identification of a new human Ebola virus species, EboBun. EboBun was isolated from the patients suffering from hemorrhagic fever in a recent outbreak in Uganda. Its worth noting, by the way, that EboBun is not the same variant currently believed to be circulating in West Africa. Clearly, the CDC needs to expand its patent portfolio to include more strains, and that may very well be why American Ebola victims have been brought to the United States in the first place. Read more below and decide for yourself... Harvesting Ebola from victims to file patents From the patent description on the EboBun virus, we know that the U.S. government: 1) Extracts Ebola viruses from patients. 2) Claims to have invented that virus. 3) Files for monopoly patent protection on the virus. To understand why this is happening, you have to first understand what a patent really is and why it exists. A patent is a government-enforced monopoly that is exclusively granted to persons or organizations. It allows that person or organization to exclusively profit from the invention or deny others the ability to exploit the invention for their own profit. It brings up the obvious question here: Why would the U.S. government claim to have invented Ebola and then claim an exclusively monopoly over its ownership? Learn more: naturalnews/046290_Ebola_patent_vaccines_profit_motive.html#ixzz3F85mCf5W
Posted on: Fri, 03 Oct 2014 23:58:58 +0000
Trending Topics
Recently Viewed Topics
© 2015